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Abstract: Beta-thalassemia and Sickle cell anemia are serious health problems in the Antalya Province of Turkey as well as World
Wide. We aimed to summarize data obtained from the prenatal diagnosis for beta-thalassemia and sickle cell anemia of 103 fetuses.
All samples were cytogenetically and molecular genetically examined during a period of 4 years. Molecular testing using RDBH and
direct DNA sequencing was performed by using amplified DNA from chorionic villi samples at 9-14 weeks of gestation, while
mutations in the parents were determined in advance. Cytogenetic analysis was carried out from a primary culture set up. Of the
103 fetuses, 26 were affected; 25 had beta-thalassemia major, and one had HbS/ beta-thalassemia. All of the affected fetuses were
theraupatically aborted with the written permission of their parents. VNTR analysis was used to eliminate maternal contamination.
IVSI-110 (G-A) was reported as the most frequent allele(50.4%) in all fetuses. Heterozygosity for IVSI-110 was the most prevalent
combination. Of the 26 affected fetuses, one was found to have a 46,XY/47,XY,+22 mosaic karyotype. On the other hand, one fetus
with normal genotype for beta-globin gene was cytogenetically found to have a 45,X karyotype. As a result, we suggest that for
accurate genetic counselling the CV and other samples obtained for molecular prenatal testing of the beta-thalassemia should also
be studied to identify possible chromosomal abnormalities.
Key Words: beta-globin gene, beta-thalassemia, sickle cell anemia, prenatal diagnosis, Antalya

Introduction
Beta-thalassemia is the most common hereditary
disease and is characterized by reduced synthesis or
absence of the beta-globin chain of hemoglobin (1-3).
Beta-thalassemia creates a serious health problem in
Turkey, especially in the Antalya region (4-6). The
frequency of β-thalassemia carriers in the Antalya
Province is 10.2% due to the high rate of consanguinity
(4), while the frequency of β-thalassemia throughout
Turkey was reported to be 2 % (7). The heterogeneity of
β-thalassemia is associated with more than 34 different
mutations in Turkey (8). The prenatal diagnosis is
performed with several molecular methods by using
chorionic villi (CV) sampling, amniotic fluid, and cord
blood (8). Due to the high consanguinity rate (35.17%)
(9) and high frequency of β-globin gene mutation
carriers, a prenatal diagnosis program was needed and
we set up a laboratory in 2000 to screen the globin gene

mutations in Antalya. In this study, we aimed to analyse
the CV samples for both mutation screening of the betaglobin gene and chromosomal abnormalities, using the
same sample divided in two parts for each case, in 103
fetuses.

Materials and Methods
The cases diagnosed as carriers by Hb electrophoresis
were referred to our laboratory from the Department of
Perinatology for mutational analysis of β-globin gene. CV
samples were obtained by transabdominal processing at
9-14 weeks of gestation. Maternal parts were eliminated
under the dissection microscope. The CV sample was
divided into two parts; one of these was used for
screening β-globin gene mutations and the other was
used for tissue culture to analyse the chromosomal
abnormalities by standard methods.
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The reverse dot blot hybridization (RDBH) kit (22
mutations for Beta-globin Strip Assay, VienLab) and
dideoxy termination chain of DNA sequencing were used
to determine the mutations of the β-globin gene (10).
When the mutation found in the fetus was the same
mutation as her/his mother, a variable number of tandem
repeat (VNTR) markers (ApoB, MCT, IgJH, and D4S95)
were used to avoid maternal contamination (11).

Results
Molecular analysis of 206 chromosomes revealed 14
different mutations in the β-globin gene including a very
rare mutation, Codon 22 (A-C), which is detected by
sequence analysis of the amplified β-globin gene. Results
are listed in table 1. IVSI-110 was the most frequently
observed β-thalassemia mutation (50.4%), followed by
IVSI-6 (9.7%), IVSII-1 (7.7%), IVSII-745 (7.7%), IVSI-1
(5.7%), and Codon 5 (4.7%). Codon 22 (A-C) mutation
was firstly identified in a fetus at risk and his mother who
was a carrier. Heterozygosity for IVSI-110 appears as the
most common genotype, with a percentage of 27.1
among all heterozygous genotypes associated with betathalassemia traits. HbS constituted 2.7% of all mutations
detected in a total of 103 fetuses. Homozygosity for IVSI110, Codon 39, IVSI-1, and IVSI-6 mutations (Table 2),
and compound heterozygosity in various combinations
for IVSI-110, IVSII-745, IVSI-6, IVSI-1, IVSII-1, IVSI-5,
Codon 5, Codon 8, Codon 22, and HbS mutations were
Table 1.

Frequencies of beta-globin gene mutations detected
prenatally.

Patients
Type of Mutation

n

%

IVSI-110/IVSI-110
Cod39/Cod39
IVSI-1/IVSI-1
IVSI-6/IVSI-6

10
1
1
1

76.9
7.6
7.6
7.6

Total:

13

100.0

* 13 of 26 affected fetuses had compound heterozygous mutations for
beta globin gene.

detected in 25 fetuses who were later aborted with the
written permission of the families. Fifty-eight fetuses
were found to be heterozygous for the above mentioned
mutations, and the remaining fetuses were found to have
the normal genotype for β-globin gene. Two fetuses were
found to have abnormal karyotypes, namely 45,X with
normal genotype and 46,XY/ 47,XY,+22 with IVSI110/IVSII-745 genotype (Table 3). Karyotypes were
confirmed by amniosynthesis, and were aborted with
written permission from their families.
Table 3. Abnormal karyotypes in CV samples of 103 fetuses analysed.
Karyotype

Genotype for Beta-globin Gene

45, X*

Normal/Normal

46,XY[11]/47,XY,+22[39]

IVSI-110/IVSII-745

* Karyotype was confirmed with amniocentesis to eliminate the
placental mosaicism.

Discussion

Chromosome
Type of Mutation
n

%

IVSI-110 (G-A)
IVSI-6 (T-C)
IVSII-1 (G-A)
IVSII-745 (G-A)
IVSI-1 (G-A)
Cod5 (-CT)
-30 (T-A)
HbS
Cod8 (-AA)
Cod39 (C-T)
IVSII-848 (C-A)
IVSI-5 (G-T)
Cod44 (-C)
Cod22 (A-C)

52
10
8
8
6
5
3
3
2
2
1
1
1
1

50.4
9.7
7.7
7.7
5.7
4.7
2.7
2.7
1.7
1.7
0.9
0.9
0.9
0.9

Total:

103

100.0
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Table 2. Frequencies and percentage of homozygous genotypes.

Hemoglobinopathies are a major public health
problem, causing both severe socio-economic and
psychologic debilitation in the population due to
symptomatic care and hospitalization. Therefore, since
1999, we have been performing the prenatal diagnosis of
β-thalassemia, which is seen frequently in the Antalya
Province of the country in our molecular genetic
laboratories. In recent years, the number of prenatal
diagnoses have been increased by conferences and
seminars given by experts to the public. As a result, 103
CV samples for prenatal diagnosis were analysed at 9-14
weeks. All of the CV samples could evaluated both for
beta-globin gene mutations and possible chromosomal
abnormalities. There was no miscarriage after CV
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sampling. All 26 affected fetuses were aborted according
to the decision of the parents. The results of the
molecular prenatal diagnosis were available within 4+1
days after sampling. To eliminate the risk of maternal
contamination, VNTR analysis using ApoB, MCT, IgJH,
and D4S95 alleles was performed, when the genotype of
the fetus was found to be identical to that of the mother.
There has been no misdiagnosis in our laboratory to date.
Our results show similarities with those of other
groups that study the prenatal diagnosis of β-thalassemia
and sickle cell anemia (8,12). We performed cytogenetic
analysis, which was not carried out in other studies,
regarding molecular analysis of β-globin gene in Turkey,
in addition to molecular analysis on the CV samples. The
abnormal karyotypes detected from CV samples revealed
that cytogenetic analysis could also be useful in detecting
genetic defects in fetuses, because a postnatal case who
coinherited
Down
syndrome
and
compound
heterozygosity for IVSI-110 and IVSII-745 mutations
was reported for the first time (13). Cytogenetic analysis
along with mutation screening requires only one invasive
procedure.

in Antalya and nearby towns and villages, one of the
regions with the highest frequency of beta-thalassemia
mutations in Turkey. Also, we aim to record all the
carriers and patients for β-thalassemia using a program
via Thalassemia Unit, Faculty of Medicine, Akdeniz
University, in Antalya, in addition to discovering novel and
rare mutations in the rich genetic pool of our region, in
order to reduce the frequency of consanguineous
marriages and hemoglobinopathies, and to educate the
population and inform the physicians in our region.

Acknowledgments
This study was supported by the Research Foundation
of Akdeniz University.
Corresponding author:
‹brahim KESER
Akdeniz University, Faculty of Medicine,
Department of Medical Biology and Genetics,
TR-07070, Antalya - TURKEY
E-Mail: keser@akdeniz.edu.tr

In conclusion, our data is valuable in that it includes
the mutation screening of patients for prenatal diagnosis
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